Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

12.2K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.2K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

34
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
34
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.8K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers.

Antimicrobial agents and chemotherapy·2026
Same author

Evaluating Short Versus Prolonged Course of Antibiotic Therapy in Adult Patients With Ventilator-Associated Pneumonia Due to Non-lactose-Fermenting Gram-Negative Bacilli.

Journal of pharmacy practice·2026
Same author

Integrating Social and Emotional Care Across the First Thousand Days in Safety-Net Health Care.

Pediatrics·2026
Same author

Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving Enterobacterales.

Microbiology spectrum·2026
Same author

Professional identity formation in pharmacy residents: A scoping review.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

Food insecurity and COVID-19-related experiences among people with HIV: A mixed methods analysis and conceptual framework.

PloS one·2026
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Related Experiment Video

Updated: Aug 29, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

13.9K

Comparative Outcomes of Candida auris Bloodstream Infections: A Multicenter Retrospective Case-Control Study.

Samuel P Simon1, Rosanna Li1, Michael Silver1

  • 1Maimonides Medical Center, Brooklyn, New York, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|September 5, 2022
PubMed
Summary
This summary is machine-generated.

Candida auris bloodstream infections (BSIs) do not increase mortality risk compared to other Candida BSIs. However, patients with Candida auris experienced a higher rate of microbiologic recurrence after treatment.

Keywords:
Candida auriscandidemiaechinocandinmicafungin

More Related Videos

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
03:24

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging

Published on: March 22, 2024

1.6K
Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.2K

Related Experiment Videos

Last Updated: Aug 29, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

13.9K
Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
03:24

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging

Published on: March 22, 2024

1.6K
Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.2K

Area of Science:

  • Infectious Diseases
  • Mycology
  • Clinical Microbiology

Background:

  • Bloodstream infections (BSIs) pose significant challenges in healthcare settings.
  • Candida auris is an emerging multidrug-resistant fungal pathogen causing invasive infections.
  • Comparing clinical outcomes of Candida auris BSIs with other Candida species is crucial for effective management.

Purpose of the Study:

  • To compare clinical characteristics and outcomes of patients with bloodstream infections (BSIs) caused by Candida auris versus other Candida species.
  • To evaluate the impact of Candida auris on mortality and clinical failure rates.
  • To assess the risk of microbiologic recurrence in Candida auris BSIs.

Main Methods:

  • A multicenter retrospective case-control study was conducted between 2016 and 2020.
  • Included patients aged ≥18 years with positive blood cultures for Candida spp. treated with echinocandins.
  • Primary outcome: 30-day mortality; secondary outcomes: 14-day clinical failure, 90-day mortality, 60-day microbiologic recurrence, and in-hospital mortality.

Main Results:

  • Out of 196 patients, 83 had Candida auris candidemia.
  • Candida auris BSI was not associated with increased 30-day or 90-day mortality rates after inverse propensity adjustment.
  • A significantly higher risk of 60-day microbiologic recurrence was observed in patients with Candida auris candidemia (aOR, 4.461; P = .045).

Conclusions:

  • Candida auris BSIs are not associated with higher mortality compared to infections caused by other Candida species.
  • The rate of microbiologic recurrence is notably higher in patients with Candida auris candidemia.
  • These findings highlight the importance of monitoring for recurrence in Candida auris infections.